Skip to main content

Lisata Therapeutics to Present at the 2025 BIO International Convention

BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will present a corporate overview at the upcoming 2025 BIO International Convention taking place in Boston, MA from June 16 – 19, 2025. Dr. Mazzo’s presentation is scheduled for Tuesday, June 17th at 11:15 a.m. Eastern Time in Room 153A. To register for the conference and schedule a one-on-one meeting with Lisata’s management, please visit https://www.bio.org/events/bio-international-convention/registration. About Lisata Therapeutics Lisata Therapeutics is a clinical-stage pharmaceutical...

Continue reading

Veru to Participate in the Virtual BTIG Obesity Health Forum

MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the company will be participating in one-on-one meetings and a fire side chat presentation with investors at the virtual BTIG Obesity Health Forum on June 18, 2025. About Veru Inc.Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight reduction by GLP-1 RA...

Continue reading

DAVIDsTEA Announces Date of First Quarter Fiscal 2025 Earnings

MONTREAL, June 11, 2025 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announced today that its financial results for the first quarter of Fiscal 2025 will be released before markets open on June 17, 2025. The Company will host a webcast same day at 8:30 a.m. Eastern Time to discuss the financial results. Details of the webcast Via the internet at: www.davidstea.com, in the “investor” section, or at: https://www.gowebcasting.com/14086 An online archive of the webcast will be available within two hours of the conclusion of the call and will remain available for 30 days. About DAVIDsTEADAVIDsTEA offers a specialty branded selection of high-quality proprietary loose-leaf teas, pre-packaged teas, tea sachets, tea-related accessories and gifts...

Continue reading

Aterian’s PurSteam and Mueller Living Brands Launch Products in Walmart Stores

Innovative Appliances Designed to Enhance Everyday Living, Expand Retail Reach, and Strengthen Aterian’s Brand Portfolio SUMMIT, N.J., June 11, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the national launch of two of its most innovative home appliances – the PurSteam Steam Station Max and the Mueller Living Cordless Portable Vacuum Sealer – now available nationwide across Walmart locations. “These launches reflect Aterian’s broader mission to expand our omni-channel presence by bringing high-quality consumer products to both digital and physical retail platforms,” said Arturo Rodriguez, Chief Executive Officer of Aterian. “The increased brand visibility, coupled with mass-market accessibility, is designed to strengthen the Company’s growth trajectory and retail...

Continue reading

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively pursue FDA clearance in connection with planned expansion into broader U.S. markets in 2025 NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an update on its growing footprint in the U.S. Forensic Use Only Market through its strategic partnership with SMARTOX, a Texas-based leader in drug and alcohol screening services. SMARTOX supports clients across corrections, drug courts, rehabilitation centres, and other forensic environments....

Continue reading

Robinhood Markets, Inc. Reports May 2025 Operating Data

MENLO PARK, Calif., June 11, 2025 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for May 2025.Funded Customers at the end of May were 25.9 million (up about 5 thousand from April 2025, up 1.8 million year-over-year). In May, Funded Customers grew by approximately 5 thousand after the impact of required escheatment of approximately 100 thousand low-balance accounts.Total Platform Assets at the end of May were $255 billion (up 10% from April 2025, up 89% year-over-year). Net Deposits were $3.5 billion in May, or a 18% annualized growth rate relative to April 2025 Total Platform Assets. Over the last twelve months, Net Deposits were $59.1 billion, or an annual growth rate of 44% relative to May 2024 Total Platform Assets.Equity Notional Trading Volumes were...

Continue reading

SEALSQ Extends Relationship with Landis+Gyr to Offer Utilities Enhanced PKI Services for AMI Network and Meter Security

Geneva, Switzerland, June 11, 2025 (GLOBE NEWSWIRE) — SEALSQ’s advanced Public Key Infrastructure (PKI) tool, INeS, was selected by Landis+Gyr to provide 30 million digital certificates for smart meters being deployed in the Asia Pacific region starting this summer SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that it is partnering with Landis+Gyr (SIX: LAND), a leading global smart grid and energy management technology company to provide utilities with a flexible public key infrastructure solution. SEALSQ’s advanced Public Key Infrastructure (PKI) tool, INeS, was selected by Landis+Gyr to provide 30 million digital certificates for smart meters being deployed...

Continue reading

Draganfly Announces Pricing of US$13.75 Million Public Offering

Saskatoon, SK., June 11, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the pricing of its public offering (the “Offering”) of 5,500,000 units, with each unit consisting of one common share and one warrant to purchase one common share. Each unit is to be sold at a public offering price of US$2.50, for gross proceeds of approximately US$13.75 million, before deducting placement agent discounts and offering expenses. The warrants will have an exercise price of CA$5.0768 (or US$3.71) per share, are exercisable immediately and will expire five years following the date of issuance. Maxim Group LLC is acting as sole placement agent for the Offering. Draganfly currently intends to use the net proceeds from the Offering...

Continue reading

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

Transaction brings OSA diagnostic revenue to Vivos, plus Vivos’ highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area Transaction also completes Vivos’ business model pivot to target high patient volume centers and higher margin revenues Over $11 million in new financing secured by Vivos, including a senior secured loan from Streeterville Capital and an equity private placement by existing investor New Seneca Partners LITTLETON, Colo., June 11, 2025 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leader in delivering and promoting sleep wellness and health through its proprietary, non-invasive treatments for obstructive sleep apnea (OSA), today announced the closing of its acquisition of the operating assets of The Sleep Center of Nevada...

Continue reading

Black Hills Corp. Receives Approval For 99 MW Dispatchable Generation Resource in South Dakota

RAPID CITY, S.D., June 11, 2025 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that its South Dakota electric utility subsidiary serving South Dakota and eastern Wyoming has received approval from the Wyoming Public Service Commission for a certificate of public convenience and necessity (CPCN) that supports the need for its Lange II Project, a 99 MW dispatchable generation resource in Rapid City, South Dakota. The approval allows commencement of construction of the project, which addresses a capacity deficit resulting from the retirement of other aging generation units, as well as an increase in planning reserve margin to ensure the utility has a reliable energy supply. Lange II will include six reciprocating internal combustion engines (RICE) with dual-fuel optionality of natural gas and diesel, and related...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.